One of the causes of individual differences in effectiveness of AT1 receptors blockers and ACE inhibitors in the cardiovascular diseases might result from different role of these compounds in the regulation of cardiovascular reactions to stress. This evidence concerns the gene ACE and cardiovascular disorder.